Lack of management of cardiovascular risk factors in type 2 diabetic patients

International Journal of Clinical Practice

Volumn 61, Issue 1, 2007, Pages 39-44

  Yun, K E ^a   Park, M J ^a   Park, Hye Soon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; EDUCATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK MANAGEMENT;

ALBUMINURIA; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 33847125365     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01154.x     Document Type: Article

References (25)

1. European Arterial Risk Policy Group on behalf of the International Diabetes Federation European Region. A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 1997; 14: 611-21.
2. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28 (Suppl. 1): 615-40.
3. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-9.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
6. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
7. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26 (Suppl. 1): S33-50.
8. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
9. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
10. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med 2002; 112: 603-9.
11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93.
12. IDF Press Events. Background information on the global guideline for type 2 diabetes 2005. Available from http://www.idf.org/webdata/docs/ background_gguideline_final.pdf, accessed 13 September 2005.
13. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.
14. Korea National Statistical Office. 2003 Report of Statistics in Mortality in Korean. Seoul: Korea National Statistical Office, 2004.
15. Korea National Statistical Office. The Cause of death statistics 2003. Seoul: Korea National Statistical Office, 2004.
16. Freedman DS, Srinivasan SR, Cresanta JL, Webber LS, Berenson GS. Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins. Pediatrics 1987; 80: 789-96.
17. Mehler PS, Esler A, Estacio RO, MacKenzie TD, Hiatt WR, Schrier RW. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes. Am J Med 2003; 114: 377-82.
18. Park SB, Lee KH, Woo SS, Park HS, Cho HJ. Quality assessment about management of hypercholesterolemia patient. J Korean Acad Fam Med 1996; 17: 438-43.
19. Barrett-Connor E. Does hyperglycemia really cause coronary heart disease? Diabetes Care 1997; 20: 1620-3.
20. Berlowitz DR, Ash AS, Hickey EC et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-63.
21. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998; 21: 1391-6.
22. Winocour PH. Effective diabetes care: a need for realistic targets. BMJ 2002; 324: 1577-80.
23. Rothman RL, Malone R, Bryant B et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118: 276-84.
24. Levetan CS, Dawn KR, Robbins DC, Ratner RE. Impact of computer-generated personalized goals on HbA(1c). Diabetes Care 2002; 25: 2-8.
25. Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC. Impact of computer-generated personalized goals on cholesterol lowering. Value Health 2005; 8: 639-46.